Bispecific inhibitor can combat a wide range of coronaviruses, including Paxlovid-resistant variants

A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid. This promising inhibitor, named TMP1, offers hope for more effective and resilient treatments against future outbreaks. A patent has been filed for further exploration in clinical applications.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup